ResearcherJohns Hopkins UniversityActive in the last 2 years
Norman G. Nicolson
Matched on ORCID iD 0000-0002-9986-6327; OpenAlex author ID A5014363727. Sources: OpenAlex.
Their work
- Papers
- 4 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 24
2020: 1 paper · 2021: none · 2022: none · 2023: 1 paper · 2024: none · 2025: none · 2026: 2 papers
Papers 4
- Patient-derived Organoid Pharmacotyping as a Predictive Tool for Therapeutic Selection in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1097/sla.0000000000006517↗
- Cancer-Associated Fibroblasts Promote Epithelial-Mesenchymal Transition and Classical to Basal Subtype Shift in Pancreatic Cancer. Co-author DOI 10.1158/0008-5472.can-25-0331↗
- Seeking the Real Benefits of Laparoscopic Pancreaticoduodenectomy for Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1001/jamasurg.2023.5219↗
- Association of Treatment Inequity and Ancestry With Pancreatic Ductal Adenocarcinoma Survival. First author DOI 10.1001/jamasurg.2019.5047↗
Closest collaborators
The 24 strongest of 24 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Jin Peng He · 3 shared papers, 2023–2026 · strength 0.82
- Paper Seeking the Real Benefits of Laparoscopic Pancreaticoduodenectomy for Pancreatic Ductal Adenocarcinoma. DOI 10.1001/jamasurg.2023.5219↗
- Paper Patient-derived Organoid Pharmacotyping as a Predictive Tool for Therapeutic Selection in Pancreatic Ductal Adenocarcin… DOI 10.1097/sla.0000000000006517↗
- Paper Cancer-Associated Fibroblasts Promote Epithelial-Mesenchymal Transition and Classical to Basal Subtype Shift in Pancrea… DOI 10.1158/0008-5472.can-25-0331↗
- William Reece Burns · 2 shared papers, 2026 · strength 0.43
- Paper Patient-derived Organoid Pharmacotyping as a Predictive Tool for Therapeutic Selection in Pancreatic Ductal Adenocarcin… DOI 10.1097/sla.0000000000006517↗
- Paper Cancer-Associated Fibroblasts Promote Epithelial-Mesenchymal Transition and Classical to Basal Subtype Shift in Pancrea… DOI 10.1158/0008-5472.can-25-0331↗
- Elana Judith Fertig · 2 shared papers, 2026 · strength 0.43
- Paper Patient-derived Organoid Pharmacotyping as a Predictive Tool for Therapeutic Selection in Pancreatic Ductal Adenocarcin… DOI 10.1097/sla.0000000000006517↗
- Paper Cancer-Associated Fibroblasts Promote Epithelial-Mesenchymal Transition and Classical to Basal Subtype Shift in Pancrea… DOI 10.1158/0008-5472.can-25-0331↗
- Christopher R. Shubert · 2 shared papers, 2026 · strength 0.43
- Paper Patient-derived Organoid Pharmacotyping as a Predictive Tool for Therapeutic Selection in Pancreatic Ductal Adenocarcin… DOI 10.1097/sla.0000000000006517↗
- Paper Cancer-Associated Fibroblasts Promote Epithelial-Mesenchymal Transition and Classical to Basal Subtype Shift in Pancrea… DOI 10.1158/0008-5472.can-25-0331↗
- Samantha R. Guinn · 2 shared papers, 2026 · strength 0.43
- Paper Patient-derived Organoid Pharmacotyping as a Predictive Tool for Therapeutic Selection in Pancreatic Ductal Adenocarcin… DOI 10.1097/sla.0000000000006517↗
- Paper Cancer-Associated Fibroblasts Promote Epithelial-Mesenchymal Transition and Classical to Basal Subtype Shift in Pancrea… DOI 10.1158/0008-5472.can-25-0331↗
- Kelly J. Lafaro · 2 shared papers, 2026 · strength 0.43
- Paper Patient-derived Organoid Pharmacotyping as a Predictive Tool for Therapeutic Selection in Pancreatic Ductal Adenocarcin… DOI 10.1097/sla.0000000000006517↗
- Paper Cancer-Associated Fibroblasts Promote Epithelial-Mesenchymal Transition and Classical to Basal Subtype Shift in Pancrea… DOI 10.1158/0008-5472.can-25-0331↗
- Elizabeth M. Jaffee · 2 shared papers, 2026 · strength 0.43
- Paper Patient-derived Organoid Pharmacotyping as a Predictive Tool for Therapeutic Selection in Pancreatic Ductal Adenocarcin… DOI 10.1097/sla.0000000000006517↗
- Paper Cancer-Associated Fibroblasts Promote Epithelial-Mesenchymal Transition and Classical to Basal Subtype Shift in Pancrea… DOI 10.1158/0008-5472.can-25-0331↗
- Jacquelyn W. Zimmerman · 2 shared papers, 2026 · strength 0.43
- Paper Patient-derived Organoid Pharmacotyping as a Predictive Tool for Therapeutic Selection in Pancreatic Ductal Adenocarcin… DOI 10.1097/sla.0000000000006517↗
- Paper Cancer-Associated Fibroblasts Promote Epithelial-Mesenchymal Transition and Classical to Basal Subtype Shift in Pancrea… DOI 10.1158/0008-5472.can-25-0331↗
- Richard A. Burkhart · 1 shared paper, 2026 · strength 0.24
- Toni T. Seppälä · 1 shared paper, 2026 · strength 0.24
- Jae Woo Lee · 1 shared paper, 2026 · strength 0.19
- Jacob T. Mitchell · 1 shared paper, 2026 · strength 0.19
- Daniel J. Zabransky · 1 shared paper, 2026 · strength 0.19
- Nicole Groß · 1 shared paper, 2026 · strength 0.19
- Richard Andrew Burkhart · 1 shared paper, 2026 · strength 0.19
- Kylie Belanger · 1 shared paper, 2026 · strength 0.19
- Luciane Tsukamoto Kagohara · 1 shared paper, 2026 · strength 0.19
- Yeonju Cho · 1 shared paper, 2026 · strength 0.19
- Michael Goggins · 1 shared paper, 2026 · strength 0.19
- Won Jin Ho · 1 shared paper, 2026 · strength 0.19
- Lei Zheng · 1 shared paper, 2026 · strength 0.19
- John W. Kunstman · 1 shared paper, 2020 · strength 0.15
- Danielle R. Heller · 1 shared paper, 2020 · strength 0.15
- Nita Ahuja · 1 shared paper, 2020 · strength 0.15
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.